NCT00556270已完成不适用
Matrifen for Therapy of Severe, Chronic Pain.
适应症
干预措施
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- Nycomed
- 入组人数
- 3,000
- 试验地点
- 1
- 主要终点
- Treatment success, efficacy of Matrifen
研究概览
简要总结
The aim of the study is to evaluate the efficacy and safety of matrifen in patients with severe and chronic pain who can only be sufficiently treated with opioid analgesics (WHO class 3).
研究设计
- 研究类型
- Observational
- 观察模型
- Case Only
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究组 & 干预措施
Matrix II
干预措施: Matrifen (Drug)
结局指标
主要结局
Treatment success, efficacy of Matrifen
时间窗: within 1 month
次要结局
- Safety and tolerability of fentanyl and the transdermal system, quality of life(within 1 month)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Matrifen® for Therapy of Severe Chronic Pain®Severe Chronic PainNCT00699335Nycomed5,308
撤回
不适用
Efficacy of "Pain Gear" in Patients With Chronic Musculoskeletal PainChronic Musculoskeletal DiseaseNCT02974023PharmEvo Pvt Ltd
终止
3 期
Study of Ampion for the Treatment of Pain and Function in Patients With Severe Osteoarthritis of the Knee.Severe Osteoarthritis of the KneeNCT03988023Ampio Pharmaceuticals. Inc.1,043
已完成
3 期
A Study of Extended-Release Hydrocodone/Acetaminophen (Vicodin CR®) in Subjects With Acute Pain Following BunionectomyPainNCT00402792Abbott150
已完成
2 期
A Study Comparing the Analgesic Efficacy and Safety of Extended Release Hydrocodone/Acetaminophen (Vicodin® CR)and Placebo in Subjects With OsteoarthritisPainNCT00404183Abbott120